Medrol (Methylprednisolone) 4 mg Dosepak and 2‑32 mg Tablets: Prescription Corticosteroid 6-Day Taper for Acute Inflammation, Allergic Reactions, and MS Exacerbations

Information last reviewed: May 2026 — for educational purposes only.

Medrol (methylprednisolone) is a synthetic glucocorticoid with approximately 5× the anti-inflammatory potency of cortisol (and approximately 1.25× the potency of prednisone on a milligram basis). It is used both for acute short-course inflammatory conditions (via the convenient Medrol Dosepak — a pre-packaged 6-day tapered course of 4 mg tablets) and for longer-term immunosuppression in higher doses. High-dose IV methylprednisolone (Solu-Medrol 1 g/day for 3–5 days) is the standard treatment for acute multiple sclerosis relapse, acute optic neuritis, and acute spinal cord injury (controversial for SCI), delivered in hospital or infusion centre settings. Oral methylprednisolone is used for inflammatory conditions, severe allergic reactions, asthma exacerbations, and contact dermatitis where a structured tapering course is clinically appropriate.

The Medrol Dosepak is one of the most commonly prescribed short-course corticosteroid regimens in primary care. The blister-pack contains 21 tablets of 4 mg methylprednisolone arranged with day-by-day dosing instructions: starting at 6 tablets on day 1 (24 mg) and tapering down by one tablet per day to 1 tablet on day 6 (4 mg). The total course delivers a structured taper designed to treat the acute condition and allow the HPA axis to resume normal cortisol production as the dose decreases toward physiological levels. Methylprednisolone 4 mg is approximately equivalent to prednisone 5 mg in anti-inflammatory effect.

What Is Methylprednisolone?

Methylprednisolone is the 6-alpha-methylated derivative of prednisolone — one chemical modification that enhances anti-inflammatory potency and reduces mineralocorticoid activity compared to prednisolone itself. Like other glucocorticoids, it acts on nuclear glucocorticoid receptors to modulate gene transcription, suppressing inflammatory pathways. Its biological half-life is 12–36 hours, intermediate between prednisolone (12–36 h) and dexamethasone (36–54 h), making twice-daily dosing optional but once-daily dosing typically sufficient for oral use. It does not require hepatic conversion to an active metabolite (unlike prednisone, which is a prodrug converted to prednisolone).

Prescription Status

Methylprednisolone is prescription-only in the United States. The Medrol Dosepak, despite being a pre-packaged convenience product, remains an Rx item. IV Solu-Medrol is hospital/clinic use only and requires physician order.

Strengths and Available Forms

• Medrol Dosepak — 4 mg tablets (21 tablets) — pre-packaged 6-day tapering regimen; most commonly dispensed form: Day 1: 6 tablets (24 mg); Day 2: 5 tablets (20 mg); Day 3: 4 tablets (16 mg); Day 4: 3 tablets (12 mg); Day 5: 2 tablets (8 mg); Day 6: 1 tablet (4 mg) — all taken as divided doses throughout the day with food
• Methylprednisolone 2 mg tablets
• Methylprednisolone 4 mg tablets — individual tablets for custom dosing
• Methylprednisolone 8 mg tablets
• Methylprednisolone 16 mg tablets — for moderate-to-severe conditions requiring higher doses
• Methylprednisolone 32 mg tablets — high-dose oral for severe inflammatory conditions
• Solu-Medrol (methylprednisolone sodium succinate) IV/IM injection — 40/125/500 mg/1 g vials; hospital use for MS relapse (1 g/day × 3–5 days), acute asthma, spinal cord injury, anaphylaxis; not for community dispensing

Price of Medrol and Generic Methylprednisolone

Generic methylprednisolone tablets and the Dosepak equivalent are inexpensive — the 6-day Dosepak typically costs $10–30 cash price. Brand-name Medrol Dosepak is more expensive. Insurance usually covers both. IV Solu-Medrol in hospital is billed separately through facility fees.

Frequently Asked Questions

How should the Medrol Dosepak be taken each day?

The blister pack has printed instructions for each day. On day 1, take the 6 tablets spread throughout the day (e.g. 3 with breakfast, 2 with lunch, 1 with dinner — or as directed). Many clinicians recommend taking the full day's dose in the morning to mimic the body's natural cortisol circadian peak and minimise sleep disruption (corticosteroids taken in the evening commonly cause insomnia). Taking tablets with food reduces GI upset, which is a common complaint for even short steroid courses. Complete all 6 days fully — do not stop early even if feeling better, as abrupt discontinuation partway through a short course can occasionally cause symptom rebound.

Can methylprednisolone cause mood or personality changes?

Corticosteroids including methylprednisolone can cause significant neuropsychiatric effects — even on short courses. Patients commonly report: euphoria or elevated mood (particularly early in a course), insomnia, irritability, anxiety, mood lability, and occasionally frank psychiatric symptoms (mania, psychosis — more common at high doses or in predisposed individuals). These effects are generally dose-dependent and resolve when the course ends. Patients with pre-existing bipolar disorder, major depression, or psychotic disorders need careful monitoring when prescribed even short steroid courses. Pre-existing psychiatric history should be discussed with the prescribing physician before starting.

What is the role of high-dose IV methylprednisolone in multiple sclerosis?

IV methylprednisolone 1,000 mg/day for 3–5 days (sometimes preceded by IV methylprednisolone 1 g/day × 3 days) is standard treatment for acute MS relapse. It accelerates the speed of recovery from acute MS exacerbations — meaning patients return to baseline faster on IV steroids than without. However, the pivotal clinical trials (OPTIC, Compirex) demonstrated that IV methylprednisolone does not alter the final degree of recovery or long-term disability progression. Therefore, treatment is indicated when the relapse is causing functionally significant disability (limb weakness, vision loss, balance disorder) sufficient to warrant the side effects and inconvenience of a 3–5 day infusion course. Mild sensory symptoms that do not significantly impair function may not warrant steroid treatment.

← Back to Corticosteroids